Filter Results:
(604)
Show Results For
- All HBS Web
(1,032)
- People (4)
- News (249)
- Research (604)
- Events (7)
- Multimedia (24)
- Faculty Publications (397)
Show Results For
- All HBS Web
(1,032)
- People (4)
- News (249)
- Research (604)
- Events (7)
- Multimedia (24)
- Faculty Publications (397)
Sort by
- 27 Aug 2008
- Research & Ideas
Creating Leaders for Science-Based Businesses
Ph.D. in biology and a former biology professor at Harvard, has also had a 25-year career in drug development and biotech companies, leading both R&D and business functions. She teaches the MBA elective Inventing Breakthroughs and... View Details
- 30 Jun 2003
- Research & Ideas
Computer Security is For Managers, Too
each warrants. A bank, for instance, might assign the greatest amount of protection to the database that stores its customers' financial information. For a pharmaceutical company, it might be the research servers that hold data on promising View Details
- 17 Nov 2008
- Research & Ideas
Decoding the Artful Sidestep
There are two findings that we find most interesting. First, it is striking that participants failed to punish the speaker when he dodged the question asked. For example, the speaker paid no price for answering a question about the illegal View Details
Keywords: by Martha Lagace
- 12 May 2008
- Research & Ideas
Accounting Information as Political Currency
information standards in accounting (through the Financial Accounting Standards Board) and in food labeling (through the Food and Drug Administration). There are likely lessons for both regulatory agencies in such a comparative analysis. View Details
Keywords: by Martha Lagace
- 01 May 2007
- First Look
First Look: May 1, 2007
face major challenges including headline-grabbing litigation, imminent patent expirations, new technologies, rising drug development costs, generic drug substitution, international competitors, and complex... View Details
Keywords: Sean Silverthorne
- 19 Jun 2013
- Research & Ideas
Analyzing Institutions to Solve Big Problems
that marijuana was a popular treatment in the nineteenth century, and the drug was listed in the Dispensatory of the United States by the 1850s. The paper looks at how the Federal Bureau of Narcotics managed not only to illegalize the... View Details
Keywords: by Carmen Nobel & Anna Secino
- 19 Jun 2012
- First Look
First Look: June 19
312-002 McKesson, a large, diversified drug distribution and health care IT company, is considering development of new business offerings to help private practice physicians remain independent. The company, with $122 billion in 2010... View Details
Keywords: Sean Silverthorne
- 12 Feb 2019
- First Look
New Research and Ideas, February 12, 2019
Devices: Challenges and Opportunities for U.S. Regulators and Innovators By: Gordon, William J., and Ariel Dora Stern Abstract— Software has become an increasingly important component of medical device technology. Through legislation like the 21st Century Cures Act as... View Details
Keywords: Dina Gerdeman
- 27 Nov 2017
- Research & Ideas
Beware the Lasting Impression of a 'Temporary' Selfie
a prop, or exhibited nudity, drinking, or drug use. As to the impact on observers of the posts, the temporary-sharers were characterized as having worse judgment than those who shared in permanent mediums. That belief was underscored... View Details
Keywords: by Rachel Layne
- 03 Mar 2009
- First Look
First Look: March 3, 2009
Public Interest: Roche & Tamiflu Harvard Business School Case 609-061 The case focuses on the challenges of Roche maintaining a supply network for a global influenza pandemic response initiative based on its antiviral drug Tamiflu.... View Details
Keywords: Martha Lagace
- 06 Apr 2015
- Research & Ideas
After Germanwings, More Attention Needed on Employee Mental Health
chronic work stress, while only 36 percent reported their employers provided adequate support to manage it. According to the National Institute of Mental Health, some 6.7 percent of American adults experience "major depressive disorder; antidepressants are the most... View Details
- 18 Jun 2001
- Research & Ideas
When In-House Research Isn’t Enough
system: Where are the best people and ideas in your field? "If you believe that knowledge is more and more globally distributed, chances are not all the best people work for you," he declared. Can you control the leakage of ideas? The patent system and... View Details
Keywords: by Jim Aisner
- 08 Jun 2010
- First Look
First Look: June 8
case:http://cb.hbsp.harvard.edu/cb/product/810123-PDF-ENG Myelin Repair Foundation: Accelerating Drug Discovery Through Collaboration Karim R. Lakhani and Paul R. CarlileHarvard Business School Case 610-074 This case presents the Myelin... View Details
Keywords: Martha Lagace
- 14 May 2020
- Research & Ideas
What Leaders Can Do to Fight the COVID Fog
dedicated sleep space—no working from bed. Caffeine, alcohol, and other drugs can degrade sleep quality. Exercise In addition to its physical benefits, aerobic exercise notably improves clarity of thought and helps regulate negative... View Details
Keywords: by Boris Groysberg and Robin Abrahams
- 12 Oct 2006
- First Look
First Look: October 12, 2006
risky investments under profound uncertainty and long time horizons for R&D; how to learn rapidly enough to keep pace with advances in drug science knowledge; and how to integrate capabilities across a broad spectrum of scientific and... View Details
Keywords: Sean Silverthorne
- 16 Jul 2008
- Op-Ed
What Should Employers Do about Health Care?
frequently in search of a better deal, which has meant that their employees needed to switch as well. They have tried to pare back covered services, thrown up barriers to expensive drugs and treatments, and recently, begun to pass more... View Details
- 03 Oct 2006
- First Look
First Look: October 3, 2006
considering selling its royalty interest in Enbrel, Amgen's blockbuster drug for the treatment of rheumatoid arthritis. In assessing whether to sell, and at what price, the hospital must determine its value to a potential buyer as well as... View Details
Keywords: Sean Silverthorne
- 27 Feb 2020
- Sharpening Your Skills
How Following Best Business Practices Can Improve Health Care
care, but there is another cost to be accounted for. Germany May Have the Answer for Reducing Drug PricesIn Germany, drugmakers must prove that a new medication’s benefits merit a higher price than existing drugs. Making Health Insurance... View Details
- 24 May 2011
- First Look
First Look: May 24
decade. The small venture that he had started with a few of his scientist colleagues in the late 1990s to discover novel medicine in a research-driven organisation had grown into one of Europe's largest biotech firms by revenues. Their success was mainly founded on... View Details
Keywords: Sean Silverthorne
- 09 Mar 2020
- Research & Ideas
Warring Algorithms Could Be Driving Up Consumer Prices
being in second place, it’s a pretty good place to be.” Consumers end up paying more To study how pricing algorithms affect competition, MacKay and Brown collected detailed pricing data from five large, multicategory retailers selling the same over-the-counter allergy... View Details